Karl Fredrik Sjövall
Chairman at ZICCUM AB
Karl Fredrik Sjövall active positions
Companies | Position | Start | End |
---|---|---|---|
ZICCUM AB | Independent Dir/Board Member | 04/04/2017 | - |
Chairman | 04/04/2017 | - | |
Chief Executive Officer | - | 08/05/2022 | |
LIPIDOR AB | Chairman | 31/12/2019 | - |
Director/Board Member | 31/12/2017 | 31/12/2019 | |
MONIVENT AB | Chairman | 30/04/2019 | - |
Independent Dir/Board Member | 30/04/2019 | - | |
Axelero AB | Director/Board Member | 30/09/2009 | - |
Emollivet AB | Chairman | - | - |
Phargentis AB | Director/Board Member | - | - |
Career history of Karl Fredrik Sjövall
Former positions of Karl Fredrik Sjövall
Companies | Position | Start | End |
---|---|---|---|
ECTIN RESEARCH AB | Chairman | 31/12/2019 | - |
BIO VITOS PHARMA AB | Director/Board Member | - | - |
Chief Executive Officer | - | - | |
Chairman | 30/09/2015 | - | |
INHALATION SCIENCES SWEDEN AB | Chief Executive Officer | 30/04/2018 | - |
Chairman | 30/04/2018 | - | |
░░░░░░░ ░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░░░ ░░ ░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
Training of Karl Fredrik Sjövall
Chalmers University of Technology | Graduate Degree |
Statistics
International
Sweden | 13 |
Norway | 2 |
Operational
Chairman | 7 |
Chief Executive Officer | 5 |
Director/Board Member | 4 |
Sectoral
Health Technology | 9 |
Consumer Services | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 6 |
---|---|
LIPIDOR AB | Commercial Services |
INHALATION SCIENCES SWEDEN AB | Health Technology |
BIO VITOS PHARMA AB | Health Technology |
MONIVENT AB | Health Technology |
ZICCUM AB | Health Technology |
ECTIN RESEARCH AB | Health Technology |
Private companies | 6 |
---|---|
Biosergen AS
Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Health Technology |
Promore Pharma AB
Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | Health Technology |
PharmaSurgics In Sweden AB
PharmaSurgics In Sweden AB Pharmaceuticals: MajorHealth Technology PharmaSurgics is a clinical stage biotech company developing novel treatments for the prevention of harmful scarring (adhesions) after surgery. Post-surgical adhesions develop in millions of patients every year and are a source of great patient suffering and enormous healthcare expenditures. The company was founded in 2005 after extensive research done by Dr Inger Mattsby-Baltzer, PhD and Professor Kjell Olmarker MD, PhD at the Sahlgrenska Academy. PharmaSurgics is based in Göteborg, Sweden, where comprehensive in vitro and in vivo facilities have been established. | Health Technology |
Axelero AB | |
Emollivet AB | |
Phargentis AB |
- Stock Market
- Insiders
- Karl Fredrik Sjövall
- Experience